Elinzanetant for treating vasomotor symptoms associated with menopause [ID6359]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Estetrol for treating vasomotor symptoms associated with the menopause in people aged 40 to 65 ID4037Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Fezolinetant for treating vasomotor symptoms associated with the menopause [ID5071]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 21 May 2025
Menopause: identification and management (NG23)Product type:GuidanceProgramme:NICE guidelineLast updated: 7 November 2024Published: 12 November 2015
Removal, preservation and subsequent reimplantation of ovarian tissue to prevent symptoms from the menopause (IPG738)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 21 September 2022
Transvaginal laser therapy for urogenital atrophy (IPG697)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 26 May 2021
Women’s and reproductive health guidelinesStatus:In developmentProgramme:NICE HubExpected publication date: TBC